BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 12612638)

  • 1. How the ubiquitin-proteasome system controls transcription.
    Muratani M; Tansey WP
    Nat Rev Mol Cell Biol; 2003 Mar; 4(3):192-201. PubMed ID: 12612638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linking the ubiquitin-proteasome pathway to chromatin remodeling/modification by nuclear receptors.
    Kinyamu HK; Chen J; Archer TK
    J Mol Endocrinol; 2005 Apr; 34(2):281-97. PubMed ID: 15821097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rush hour at the promoter: how the ubiquitin-proteasome pathway polices the traffic flow of nuclear receptor-dependent transcription.
    Dennis AP; O'Malley BW
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):139-51. PubMed ID: 15860256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitin and control of transcription.
    Dhananjayan SC; Ismail A; Nawaz Z
    Essays Biochem; 2005; 41():69-80. PubMed ID: 16250898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Damage control: DNA repair, transcription, and the ubiquitin-proteasome system.
    Daulny A; Tansey WP
    DNA Repair (Amst); 2009 Apr; 8(4):444-8. PubMed ID: 19272841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diverse roles for ubiquitin-dependent proteolysis in transcriptional activation.
    Lipford JR; Deshaies RJ
    Nat Cell Biol; 2003 Oct; 5(10):845-50. PubMed ID: 14523392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting.
    Ciechanover A
    Cell Death Differ; 2005 Sep; 12(9):1178-90. PubMed ID: 16094394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of ubiquitin- and Ubl-binding proteins in cell signaling.
    Kirkin V; Dikic I
    Curr Opin Cell Biol; 2007 Apr; 19(2):199-205. PubMed ID: 17303403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DeSUMOylating enzymes--SENPs.
    Drag M; Salvesen GS
    IUBMB Life; 2008 Nov; 60(11):734-42. PubMed ID: 18666185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic aberrations of cullin-dependent ubiquitin ligases.
    Guardavaccaro D; Pagano M
    Oncogene; 2004 Mar; 23(11):2037-49. PubMed ID: 15021891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory mechanisms controlling biogenesis of ubiquitin and the proteasome.
    London MK; Keck BI; Ramos PC; Dohmen RJ
    FEBS Lett; 2004 Jun; 567(2-3):259-64. PubMed ID: 15178333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ubiquitins, proteasomes, sumoylation and therapeutic application today and in future for cancer and other diseases. I. Ubiquitin-proteasome system and the transcription factor NF-kappaB].
    Fuchs O; Neuwirtová R
    Vnitr Lek; 2006 Apr; 52(4):371-8. PubMed ID: 16755993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FAT10, a ubiquitin-independent signal for proteasomal degradation.
    Hipp MS; Kalveram B; Raasi S; Groettrup M; Schmidtke G
    Mol Cell Biol; 2005 May; 25(9):3483-91. PubMed ID: 15831455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A ubiquitin stress response induces altered proteasome composition.
    Hanna J; Meides A; Zhang DP; Finley D
    Cell; 2007 May; 129(4):747-59. PubMed ID: 17512408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate link between NF-kappaB activity and ubiquitin-like modifiers.
    Lang V; Rodríguez MS
    Biochem Soc Trans; 2008 Oct; 36(Pt 5):853-7. PubMed ID: 18793150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Much to know about proteolysis: intricate proteolytic machineries compromise essential cellular functions.
    Marfany G; Farràs R; Salido E; Xirodimas DP; Rodríguez MS
    Biochem Soc Trans; 2008 Oct; 36(Pt 5):781-5. PubMed ID: 18793136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yeast Pth2 is a UBL domain-binding protein that participates in the ubiquitin-proteasome pathway.
    Ishii T; Funakoshi M; Kobayashi H
    EMBO J; 2006 Nov; 25(23):5492-503. PubMed ID: 17082762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting.
    Tisdale MJ
    J Support Oncol; 2005; 3(3):209-17. PubMed ID: 15915823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A putative stimulatory role for activator turnover in gene expression.
    Lipford JR; Smith GT; Chi Y; Deshaies RJ
    Nature; 2005 Nov; 438(7064):113-6. PubMed ID: 16267558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The proteasomal system.
    Jung T; Catalgol B; Grune T
    Mol Aspects Med; 2009 Aug; 30(4):191-296. PubMed ID: 19371762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.